SCHEMBL23225701

SCHEMBL23225701

COCCOCCN(C)C(=O)OCSCN(CCOC(C)C)c1ccn(COC(=O)N(C)CCOCCOC)c1C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217954 0.68 MEN1 (0.31) —
SCHEMBL22282303 0.59 CHRNB2 (0.35) —
SCHEMBL23217972 0.57 CHRNB2 (0.36) —
SCHEMBL19002259 0.56 BLM (0.34) —
SCHEMBL22151616 0.56 BLM (0.34) —
SCHEMBL29879121 0.56 BLM (0.36) —
SCHEMBL7623228 0.56 BLM (0.36) —
SCHEMBL13162318 0.54 CHRNB2 (0.41) —
SCHEMBL5826285 0.53 BLM (0.36) —
SCHEMBL5826297 0.53 BLM (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072140-A1 PRODRUGS OF MYELOPEROXIDASE INHIBITORS BIOHAVEN THERAPEUTICS LTD. (US) 2021-04-15 — — WO disclosed
Send feedback